Navigation Links
JCI early table of contents for Jan. 16, 2013
Date:1/16/2013

Could probiotics help HIV patients?

Antiretroviral (ARV) drugs are the first line therapy for patients with HIV; however, ARV-treated, HIV-infected individuals still have a higher mortality rate than uninfected individuals. During the course of infection, HIV patients develop inflammation that damages the walls of the intestines, known as the gut mucosa, allowing intestinal microbes to escape and enter the blood stream to cause a life-threatening systemic infection. The health of the gut mucosa is significantly influenced by the complement of bacteria in the gut and there is mounting evidence that probiotic supplements benefit patients intestinal disorders, such as irritable bowel syndrome, C. difficile infection, and inflammatory bowel disease.

In this issue of the Journal of Clinical Investigation, researchers led by Jason Brenchley at the National Institute of Allergy and Infectious Disease, demonstrated that probiotic supplementation may also be beneficial for ARV-treated HIV patients. Brenchley and colleagues treated SIV-infected macaques (a model of human HIV-infection) with either ARV alone or ARV in combination with a mixture of probiotics. Macaques treated with probiotics had enhanced gastrointestinal immune function and decreased inflammation compared to macaques treated with ARV alone. In a companion article, Judith Aberg and colleagues at New York University School of Medicine discuss how these findings could benefit HIV patients.

TITLE:
Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques

AUTHOR CONTACT:
Jason M. Brenchley
NIAID NIH, Bethesda, MD, USA
Phone: 301-496-1498; E-mail: jbrenchl@mail.nih.gov

View this article at: http://www.jci.org/articles/view/66227?key=1cff041937d9040dfed7

ACCOMPANYING ARTICLE:

TITLE:
Clash of the microbes: let's bring back the good guys

AUTHOR CONTACT:
Judith Aberg
New York University School of Medicine, New York, NY, USA
Phone: 2122637300; E-mail: judith.aberg@nyumc.org

View this article at: http://www.jci.org/articles/view/66736?key=64b158b04e2a168811a3


Hepatitis B virus promotes oncogenesis through microRNA modulation

Viruses prompt oncogenic transformation by genetically altering infected cells. Several recent studies have demonstrated that viruses alter the expression of microRNAs, non-coding RNA molecules that can block the expression of target genes. In this issue of the Journal of Clinical Investigation, Xiaoje Xu and colleagues at the Beijing Institute of Biotechnology report that miR-148a is repressed by hepatitis B virus (HBV) X protein (HBx) to promote growth and metastasis of liver cancer. In normal liver cells, miR-148a represses the expression of the oncogenic protein HPIP, but the hepatitis B virus prevents expression of miR-148a, leading to increased levels of HPIP and subsequent oncogenic transformation. This study demonstrates that a cancer-associated virus promotes carcinogenesis through direct manipulation of a microRNA.

TITLE:
Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis

AUTHOR CONTACT:
Qinong Ye
Beijing Institute of Biotechnology, Beijing, CHN
Phone: (8610)68180809; Fax: (8610)68248045; E-mail: yeqn66@yahoo.com

View this article at: http://www.jci.org/articles/view/64265?key=267b145ad442aacf5c02


ALSO IN THIS ISSUE

Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation

Dynamic visualization of RANKL and Th17-mediated osteoclast function

KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs

MiR-374a activates Wnt/ β-catenin signaling to promote breast cancer metastasis

mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice

Loss of SPARC in bladder cancer enhances carcinogenesis and progression | Back to top BONE BIOLOGY

TITLE:
Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation

AUTHOR CONTACT:
Roland Baron
Harvard School of Medicine and of Dental Medicine, Boston, MA, USA
Phone: 617.432.7320 or 7325; Fax: 617.432.1897; E-mail: roland_baron@hsdm.harvard.edu

View this article at: http://www.jci.org/articles/view/64840?key=c8170fcece15001cf8c0

TITLE:
Dynamic visualization of RANKL and Th17-mediated osteoclast function

AUTHOR CONTACT:
Masaru Ishii
WPI-Immunology Frontier Research Center, Osaka University, Osaka, JPN
Phone: 81668794268; Fax: 81668798296; E-mail: mishii@ifrec.osaka-u.ac.jp

View this article at: http://www.jci.org/articles/view/65054?key=63bed6989736b83be7fd

ONCOLOGY

TITLE:
KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs

AUTHOR CONTACT:
Nabeel Bardeesy
Massachusetts General Hospital, Boston, MA, USA
Phone: 617-643-2579; E-mail: bardeesy.Nabeel@mgh.harvard.edu

View this article at: http://www.jci.org/articles/view/64535?key=aecb23f1f9fae807216b

TITLE:
MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis

AUTHOR CONTACT:
Mengfeng Li
Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, UNK, CHN
Phone: +86(20)87332748; Fax: +86(20)87331209; E-mail: limf@mail.sysu.edu.cn

View this article at: http://www.jci.org/articles/view/65871?key=3d080eabb1106f73d520

TITLE:
mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice

AUTHOR CONTACT:
Matthias Ernst
Ludwig Institute for Cancer Research Cancer Research, Melbourne, AUS
Phone: +61-3-9341-3155; Fax: +61-3-9341-3104; E-mail: matthias.ernst@ludwig.edu.au

View this article at: http://www.jci.org/articles/view/65086?key=30a0deb622897138b7bf

TITLE:
Loss of SPARC in bladder cancer enhances carcinogenesis and progression

AUTHOR CONTACT:
Dan Theodorescu
University of Colorado Denver, Aurora, CO, USA
Phone: 303-724-7135; E-mail: dan.theodorescu@ucdenver.edu

View this article at: http://www.jci.org/articles/view/64782?key=4dcefabf20a4259617c5


'/>"/>

Contact: Jillian Hurst
press_releases@the-jci.org
Journal of Clinical Investigation
Source:Eurekalert

Related medicine news :

1. New Stool Test Might Aid in Early Detection of Colon Cancer
2. An Early Start for Your Child with Autism
3. Early Study Finds Some Promise for Lung Cancer Vaccine
4. Treat Rheumatoid Arthritis Early and Aggressively: Guidelines
5. JCI early table of contents for April 9, 2012
6. Eye Tremors May Aid Early Diagnosis of Parkinsons: Study
7. Nearly 1 in 4 grandparents store prescription medicines where children can easily find them
8. First contact: Early intervention key in diagnosis and treatment of serious mental illness
9. Brain Tumor Vaccine Shows Promise in Early Trial
10. Role of Screening, Monitoring in Early Kidney Disease Unclear
11. Detecting malaria early to save lives: New optical technique promises rapid and accurate diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... , ... Our bodies are bombarded daily by environmental and lifestyle factors that ... is to adopt a more healthful diet, but too many people think that food ... Nutritionist and the creator of the Newport Beach Cleanse and 14-Day Eating Plan, disagrees ...
(Date:4/29/2016)... , ... April 29, 2016 , ... On Tuesday, April ... across the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the ... Duncan (R - Cumming), offers a 70% tax credit to individuals and corporations which ...
(Date:4/29/2016)... ... April 29, 2016 , ... The American workforce ... stability, even security. Most importantly, employees are the single most important asset in ... workers so unhappy? , Just under half of American workers are emotionally checked ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Bernie Siegel, ... "LOVE, MEDICINE and MIRACLES") addresses touchy topics related to Death live on ... Dr. Bernie Siegel, author of a plethora of essential books-to-read for physicians ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... BERLIN , April 29, 2016 ... world-leading glyco-biology expertise, today announces the appointment of Dr. ... Dr. Zurlo is an oncologist with many years ... pharmaceutical and biotechnology industries. His last role was at ... Member of the Executive Board. Previously Dr. Zurlo held ...
(Date:4/28/2016)... 2016  Marking its one year anniversary since ... cancer risk test, Color Genomics announced ... highly impact the most common hereditary cancers affecting ... Test analyzes hereditary cancer risks for breast, colorectal, ... The Color Test is physician ordered and includes ...
(Date:4/28/2016)... , April 28, 2016 Dr. ... and Ste phen ... ArisGlobal®, a leading provider of cloud-based software solutions for life ... Pharmacovigilance team to bring a wealth of insight to a growing ... pharmacovigilance knowledge. George Phillips joined ArisGlobal in ...
Breaking Medicine Technology: